ModernaTX, Inc.
4 clinical trials · 4 recruiting · INDUSTRY
Trials by ModernaTX, Inc.
RECRUITINGPhase 2NCT06735248
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged...
The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis.
Sponsor: ModernaTX, Inc.Enrolling: 18017 locations
Multiple Sclerosis
RECRUITINGPhase 4NCT07089706
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
The purpose of this study is to evaluate the immunogenicity and safety of the recommended variant-containing formulations of mRNA-1283 COVID-19 vaccine (mNEXSPIKE®) within the...
Sponsor: ModernaTX, Inc.Enrolling: 8325 locations
COVID-19
RECRUITINGNCT06333704
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
The main objective of the surveillance is to evaluate the incidence of the adverse events (AEs), and other safety related information in South-Korean population.
Sponsor: ModernaTX, Inc.Enrolling: 420620 locations
SARS-CoV-2
RECRUITINGPhase 3NCT07496450
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of...
Sponsor: ModernaTX, Inc.Enrolling: 400020 locations
Influenza